BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16616073)

  • 21. Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature.
    Gjelberg HK; Helgeland L; Liseth K; Micci F; Sandnes M; Russnes HG; Reikvam H
    Curr Oncol; 2023 Nov; 30(11):10007-10018. PubMed ID: 37999147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seropositive polyarthritis and skin manifestations in T-prolymphocytic leukemia/Sezary cell leukemia variant.
    Dybjer A; Hellquist L; Johansson B; Rydgren L; Billström R
    Leuk Lymphoma; 2000 Apr; 37(3-4):437-40. PubMed ID: 10752996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-cell prolymphocytic leukemia: a single-institution experience.
    Ravandi F; O'Brien S; Jones D; Lerner S; Faderl S; Ferrajoli A; Wierda W; Garcia-Manero G; Thomas D; Koller C; Verstovsek S; Giles F; Cortes J; Herling M; Kantarjian H; Keating M
    Clin Lymphoma Myeloma; 2005 Nov; 6(3):234-9. PubMed ID: 16354329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin and gingival lesions in a young woman with B-prolymphocytic leukemia (B-PLL).
    Panteli K; Bai M; Basioukas K; Vartholomatos G; Zioga K; Bourantas KL
    J Exp Clin Cancer Res; 2001 Sep; 20(3):447-9. PubMed ID: 11718228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of prolymphocytic leukemia.
    Dearden C
    Hematology Am Soc Hematol Educ Program; 2015; 2015():361-7. PubMed ID: 26637744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complex karyotype including chromosomal translocation (8;14) (q24;q32) in one case with B-cell prolymphocytic leukemia.
    Crisostomo RH; Fernandez JA; Caceres W
    Leuk Res; 2007 May; 31(5):699-701. PubMed ID: 16997373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in chronic lymphocytic leukemia.
    Abbott BL
    Cancer Invest; 2006; 24(3):302-9. PubMed ID: 16809159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cutaneous erythematous rash as first manifestation of T-cell prolymphocytic lymphatic leukemia].
    Beltrán Fernández L; di Martino Ortiz B; Gil Herrera J; López-Herce JA; de Portugal Alvarez J; Menárguez Palanca J
    An Med Interna; 2002 Mar; 19(3):126-9. PubMed ID: 12012759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-cell Prolymphocytic Leukemia.
    Matutes E
    Cancer Control; 1998 Jan; 5(1):19-24. PubMed ID: 10761013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in the understanding and management of T-cell prolymphocytic leukemia.
    Laribi K; Lemaire P; Sandrini J; Baugier de Materre A
    Oncotarget; 2017 Nov; 8(61):104664-104686. PubMed ID: 29262669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab-induced acute thrombocytopenia in a patient with prolymphocytic leukemia.
    Pamuk GE; Donmez S; Turgut B; Demir M; Vural O
    Am J Hematol; 2005 Jan; 78(1):81. PubMed ID: 15609288
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prolymphocytic leukemia].
    Jantunen E; Lahtinen R
    Duodecim; 1992; 108(10):955-9. PubMed ID: 1366274
    [No Abstract]   [Full Text] [Related]  

  • 33. Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene.
    Sun S; Fang W
    Biomed Pharmacother; 2020 Jun; 126():110107. PubMed ID: 32247279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Comprehensive Update on Molecular and Cytogenetic Abnormalities in T-cell Prolymphocytic Leukemia (T-pll).
    Delgado P; Starshak P; Rao N; Tirado CA
    J Assoc Genet Technol; 2012; 38(4):193-8. PubMed ID: 23183331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescent BAT-25 and BAT-26 analysis of T cell prolymphocytic leukaemia.
    Bradshaw PS; Hamoudi R; Min T; Catovsky D; Houlston RS; Yuille MR
    Leukemia; 1999 Dec; 13(12):2104-6. PubMed ID: 10602436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolymphocytic Leukaemia: an Update on Biology and Treatment.
    El-Sharkawi D; Dearden C
    Curr Oncol Rep; 2024 Feb; 26(2):129-135. PubMed ID: 38214879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [B-cell prolymphocytic leukemia].
    Uchida T; Kawachi Y
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):99-101. PubMed ID: 9851094
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetic characterization of T-PLL reveals two major biologic subgroups and JAK3 mutations as prognostic marker.
    Stengel A; Kern W; Zenger M; Perglerová K; Schnittger S; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2016 Jan; 55(1):82-94. PubMed ID: 26493028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indolent T-cell prolymphocytic leukemia: a case report and a review of the literature.
    Cavazzini F; Cuneo A; Bardi A; Castoldi G
    Am J Hematol; 2003 Oct; 74(2):145-7. PubMed ID: 14508807
    [No Abstract]   [Full Text] [Related]  

  • 40. Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia.
    Mikhaylenko N; Wahnschaffe L; Herling M; Roeder I; Seifert M
    PLoS One; 2022; 17(9):e0274463. PubMed ID: 36129940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.